Shefali Luthra, web reporter, covers consumer issues in health care. Her work has appeared in news outlets such as The Washington Post, CNN Health and npr.
Shefali Luthra
From this contributor
Marijuana warning from U.S. surgeon general lacks context
Speaking about a recent federal advisory on marijuana, Jerome Adams, U.S. surgeon general, put a new spin on long-standing admonitions about the drug.
Marijuana warning from U.S. surgeon general lacks context
By
Shefali Luthra, Kaiser Health News
15 November 2019 | 6 min read
From crib to court: Trump administration summons immigrant infants
A total of 1,500 'unaccompanied' children, from newborns to age 3, have been called in to immigration court since 1 October 2015, according to U.S. Justice Department data.
From crib to court: Trump administration summons immigrant infants
By
Christina Jewett, Shefali Luthra, Kaiser Health News
20 July 2018 | 6 min read
Immigrant children detained in U.S. may struggle to get health care
By
Shefali Luthra, Marisa Taylor, Kaiser Health News
3 July 2018 | 5 min read
Toddlers face immigration hearings in U.S. courts alone
As the White House faces court orders to reunite families separated at the U.S. border, immigrant children as young as 3 are being ordered into court for their own deportation proceedings, according to attorneys in Texas, California and Washington, D.C.
Toddlers face immigration hearings in U.S. courts alone
By
Christina Jewett, Shefali Luthra, Kaiser Health News
28 June 2018 | 7 min read
Thousands of children younger than 13 detained under U.S. border policy
The Trump administration has detained 2,322 children 12 years old or younger amid its border crackdown.
Thousands of children younger than 13 detained under U.S. border policy
By
Shefali Luthra, Marisa Taylor, Kaiser Health News
22 June 2018 | 6 min read
Explore more from The Transmitter
‘Peer review is our strength’: Q&A with Walter Koroshetz, former NINDS director
In his first week off the job, the former National Institute of Neurological Disorders and Stroke director urges U.S. scientists to remain optimistic about the future of neuroscience research, even if the executive branch “may not value what we do.”
‘Peer review is our strength’: Q&A with Walter Koroshetz, former NINDS director
In his first week off the job, the former National Institute of Neurological Disorders and Stroke director urges U.S. scientists to remain optimistic about the future of neuroscience research, even if the executive branch “may not value what we do.”
By
Angie Voyles Askham
27 January 2026 | 7 min read
Viral remnant in chimpanzees silences brain gene humans still use
The retroviral insert appears to inadvertently switch off a gene involved in brain development.
Viral remnant in chimpanzees silences brain gene humans still use
The retroviral insert appears to inadvertently switch off a gene involved in brain development.
By
Siddhant Pusdekar
27 January 2026 | 5 min read
FDA website no longer warns against bogus autism therapies, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 26 January.
FDA website no longer warns against bogus autism therapies, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 26 January.
By
Jill Adams
27 January 2026 | 2 min read